Your Article Summary
Elevated serum creatinine levels associated with fenofibrate therapy
American Journal of Health-System Pharmacy, 01/15/08
McQuade CR et al. - The case of a patient who developed clinically relevant increases in serum creatinine (SCr) levels while receiving fenofibrate therapy is reported. It was concluded that patient developed renal impairment after receiving fenofibrate for the treatment of hypertriglyceridemia
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
Antiretroviral Medications: Adverse Effects on the Kidney
Advances In Chronic Kidney Disease , 12/17/09
Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly
Nephrology Dialysis Transplantation, 12/17/09

See Latest Articles